Cargando…

Risk factors for refractory enterocutaneous fistula following button jejunostomy removal and its treatment using a novel extraperitoneal approach in patients with oesophageal cancer: a retrospective cohort study

BACKGROUND: Enterocutaneous fistula after removal of the jejunostomy tube leads to multiple problems, such as cosmetic problems, decreased quality of life, electrolyte imbalances, infectious complications, and increased medical costs. However, the risk factors for refractory enterocutaneous fistula...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamada, Teppei, Ohdaira, Hironori, Nakashima, Keigo, Nishide, Ryo, Takahashi, Junji, Ito, Eisaku, Nakaseko, Yuichi, Suzuki, Norihiko, Yoshida, Masashi, Eto, Ken, Suzuki, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700890/
https://www.ncbi.nlm.nih.gov/pubmed/36434536
http://dx.doi.org/10.1186/s12876-022-02524-2
_version_ 1784839414151643136
author Kamada, Teppei
Ohdaira, Hironori
Nakashima, Keigo
Nishide, Ryo
Takahashi, Junji
Ito, Eisaku
Nakaseko, Yuichi
Suzuki, Norihiko
Yoshida, Masashi
Eto, Ken
Suzuki, Yutaka
author_facet Kamada, Teppei
Ohdaira, Hironori
Nakashima, Keigo
Nishide, Ryo
Takahashi, Junji
Ito, Eisaku
Nakaseko, Yuichi
Suzuki, Norihiko
Yoshida, Masashi
Eto, Ken
Suzuki, Yutaka
author_sort Kamada, Teppei
collection PubMed
description BACKGROUND: Enterocutaneous fistula after removal of the jejunostomy tube leads to multiple problems, such as cosmetic problems, decreased quality of life, electrolyte imbalances, infectious complications, and increased medical costs. However, the risk factors for refractory enterocutaneous fistula (REF) after button jejunostomy removal remain unclear. Therefore, in this study, we assessed the risk factors for REF after button jejunostomy removal in patients with oesophageal cancer and reported the surgical outcomes of the novel extraperitoneal approach (EPA) for REF closure. METHODS: This retrospective cohort study included 47 patients who underwent button jejunostomy removal after oesophagectomy for oesophageal cancer. We assessed the risk factors for REF in these patients and reported the surgical outcomes of the novel EPA for REF closure at the International University of Health and Welfare Hospital between March 2013 and October 2021. The primary endpoint was defined as the occurrence of REF after removal of the button jejunostomy, which was assessed using a maintained database. The risk factors and outcomes of the EPA for REF closure were retrospectively analysed. RESULTS: REFs occurred in 15 (31.9%) patients. In the univariate analysis, REF was significantly more common in patients with albumin level < 4.0 g/dL (p = 0.026), duration > 12 months for button jejunostomy removal (p = 0.003), and with a fistula < 15.0 mm (p = 0.002). The multivariate analysis revealed that a duration > 12 months for button jejunostomy removal (odds ratio [OR]: 7.15; 95% confidence interval [CI]: 1.38–36.8; p = 0.019) and fistula < 15.0 mm (OR: 8.08; 95% CI: 1.50–43.6; p = 0.002) were independent risk factors for REF. EPA for REF closure was performed in 15 patients. The technical success rate of EPA was 88.2%. Of the 15 EPA procedures, fistula closure was achieved in 12 (80.0%). The complications of EPA (11.7%) were major leakages (n = 3) and for two of them, EPA procedure was re-performed, and closure of the fistula was finally achieved. CONCLUSION: This study suggested that duration > 12 months for button jejunostomy removal and fistula < 15.0 mm are the independent risk factors for REF after button jejunostomy removal. EPA for REF closure is a novel, simple, and useful surgical option for patients with REF after oesophagectomy.
format Online
Article
Text
id pubmed-9700890
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97008902022-11-27 Risk factors for refractory enterocutaneous fistula following button jejunostomy removal and its treatment using a novel extraperitoneal approach in patients with oesophageal cancer: a retrospective cohort study Kamada, Teppei Ohdaira, Hironori Nakashima, Keigo Nishide, Ryo Takahashi, Junji Ito, Eisaku Nakaseko, Yuichi Suzuki, Norihiko Yoshida, Masashi Eto, Ken Suzuki, Yutaka BMC Gastroenterol Research BACKGROUND: Enterocutaneous fistula after removal of the jejunostomy tube leads to multiple problems, such as cosmetic problems, decreased quality of life, electrolyte imbalances, infectious complications, and increased medical costs. However, the risk factors for refractory enterocutaneous fistula (REF) after button jejunostomy removal remain unclear. Therefore, in this study, we assessed the risk factors for REF after button jejunostomy removal in patients with oesophageal cancer and reported the surgical outcomes of the novel extraperitoneal approach (EPA) for REF closure. METHODS: This retrospective cohort study included 47 patients who underwent button jejunostomy removal after oesophagectomy for oesophageal cancer. We assessed the risk factors for REF in these patients and reported the surgical outcomes of the novel EPA for REF closure at the International University of Health and Welfare Hospital between March 2013 and October 2021. The primary endpoint was defined as the occurrence of REF after removal of the button jejunostomy, which was assessed using a maintained database. The risk factors and outcomes of the EPA for REF closure were retrospectively analysed. RESULTS: REFs occurred in 15 (31.9%) patients. In the univariate analysis, REF was significantly more common in patients with albumin level < 4.0 g/dL (p = 0.026), duration > 12 months for button jejunostomy removal (p = 0.003), and with a fistula < 15.0 mm (p = 0.002). The multivariate analysis revealed that a duration > 12 months for button jejunostomy removal (odds ratio [OR]: 7.15; 95% confidence interval [CI]: 1.38–36.8; p = 0.019) and fistula < 15.0 mm (OR: 8.08; 95% CI: 1.50–43.6; p = 0.002) were independent risk factors for REF. EPA for REF closure was performed in 15 patients. The technical success rate of EPA was 88.2%. Of the 15 EPA procedures, fistula closure was achieved in 12 (80.0%). The complications of EPA (11.7%) were major leakages (n = 3) and for two of them, EPA procedure was re-performed, and closure of the fistula was finally achieved. CONCLUSION: This study suggested that duration > 12 months for button jejunostomy removal and fistula < 15.0 mm are the independent risk factors for REF after button jejunostomy removal. EPA for REF closure is a novel, simple, and useful surgical option for patients with REF after oesophagectomy. BioMed Central 2022-11-25 /pmc/articles/PMC9700890/ /pubmed/36434536 http://dx.doi.org/10.1186/s12876-022-02524-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kamada, Teppei
Ohdaira, Hironori
Nakashima, Keigo
Nishide, Ryo
Takahashi, Junji
Ito, Eisaku
Nakaseko, Yuichi
Suzuki, Norihiko
Yoshida, Masashi
Eto, Ken
Suzuki, Yutaka
Risk factors for refractory enterocutaneous fistula following button jejunostomy removal and its treatment using a novel extraperitoneal approach in patients with oesophageal cancer: a retrospective cohort study
title Risk factors for refractory enterocutaneous fistula following button jejunostomy removal and its treatment using a novel extraperitoneal approach in patients with oesophageal cancer: a retrospective cohort study
title_full Risk factors for refractory enterocutaneous fistula following button jejunostomy removal and its treatment using a novel extraperitoneal approach in patients with oesophageal cancer: a retrospective cohort study
title_fullStr Risk factors for refractory enterocutaneous fistula following button jejunostomy removal and its treatment using a novel extraperitoneal approach in patients with oesophageal cancer: a retrospective cohort study
title_full_unstemmed Risk factors for refractory enterocutaneous fistula following button jejunostomy removal and its treatment using a novel extraperitoneal approach in patients with oesophageal cancer: a retrospective cohort study
title_short Risk factors for refractory enterocutaneous fistula following button jejunostomy removal and its treatment using a novel extraperitoneal approach in patients with oesophageal cancer: a retrospective cohort study
title_sort risk factors for refractory enterocutaneous fistula following button jejunostomy removal and its treatment using a novel extraperitoneal approach in patients with oesophageal cancer: a retrospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700890/
https://www.ncbi.nlm.nih.gov/pubmed/36434536
http://dx.doi.org/10.1186/s12876-022-02524-2
work_keys_str_mv AT kamadateppei riskfactorsforrefractoryenterocutaneousfistulafollowingbuttonjejunostomyremovalanditstreatmentusinganovelextraperitonealapproachinpatientswithoesophagealcanceraretrospectivecohortstudy
AT ohdairahironori riskfactorsforrefractoryenterocutaneousfistulafollowingbuttonjejunostomyremovalanditstreatmentusinganovelextraperitonealapproachinpatientswithoesophagealcanceraretrospectivecohortstudy
AT nakashimakeigo riskfactorsforrefractoryenterocutaneousfistulafollowingbuttonjejunostomyremovalanditstreatmentusinganovelextraperitonealapproachinpatientswithoesophagealcanceraretrospectivecohortstudy
AT nishideryo riskfactorsforrefractoryenterocutaneousfistulafollowingbuttonjejunostomyremovalanditstreatmentusinganovelextraperitonealapproachinpatientswithoesophagealcanceraretrospectivecohortstudy
AT takahashijunji riskfactorsforrefractoryenterocutaneousfistulafollowingbuttonjejunostomyremovalanditstreatmentusinganovelextraperitonealapproachinpatientswithoesophagealcanceraretrospectivecohortstudy
AT itoeisaku riskfactorsforrefractoryenterocutaneousfistulafollowingbuttonjejunostomyremovalanditstreatmentusinganovelextraperitonealapproachinpatientswithoesophagealcanceraretrospectivecohortstudy
AT nakasekoyuichi riskfactorsforrefractoryenterocutaneousfistulafollowingbuttonjejunostomyremovalanditstreatmentusinganovelextraperitonealapproachinpatientswithoesophagealcanceraretrospectivecohortstudy
AT suzukinorihiko riskfactorsforrefractoryenterocutaneousfistulafollowingbuttonjejunostomyremovalanditstreatmentusinganovelextraperitonealapproachinpatientswithoesophagealcanceraretrospectivecohortstudy
AT yoshidamasashi riskfactorsforrefractoryenterocutaneousfistulafollowingbuttonjejunostomyremovalanditstreatmentusinganovelextraperitonealapproachinpatientswithoesophagealcanceraretrospectivecohortstudy
AT etoken riskfactorsforrefractoryenterocutaneousfistulafollowingbuttonjejunostomyremovalanditstreatmentusinganovelextraperitonealapproachinpatientswithoesophagealcanceraretrospectivecohortstudy
AT suzukiyutaka riskfactorsforrefractoryenterocutaneousfistulafollowingbuttonjejunostomyremovalanditstreatmentusinganovelextraperitonealapproachinpatientswithoesophagealcanceraretrospectivecohortstudy